Navigation Links
Marijuana-Derived Drug Promises Hope In Treating Bladder Infection

Interstitial cystitis is primarily a disease of middle-aged women and is characterized by recurring discomfort or pain in the bladder and surrounding pelvic region. Symptoms vary and can include a combination of mild to severe pain, pressure and tenderness in the bladder and pelvic area; and an urgent and/or frequent need to urinate. // Additionally, the bladder wall may become scarred or irritated, and pinpoint bleeding may appear on the bladder wall.

There appears to be no definitive treatment for interstitial cystitis. The therapy usually employed frequently affords partial relief, but it may be completely ineffective.

"Interstitial cystitis is a difficult disease to treat, and not all treatments work well on all patients," said Michael Chancellor, M.D., professor of urology at the University of Pittsburgh School of Medicine. "Any new option we can give our patients to alleviate their painful symptoms is very exciting."

General treatment involves the prescription of sedatives but seldom afford relief. Associated urinary infection is treated with appropriate antibiotics. Most patients respond to the conservative management. Persistent symptoms may require surgical intervention.

IP 751, the principal active ingredient of marijuana has been found to effectively suppress pain and bladder over activity in hypersensitive bladder disorders such as interstitial cystitis (IC). However, the study has been conducted only on animal models.

IP 751 is a potent anti-inflammatory and a powerful analgesic, although the mechanisms by which it works are unknown.

IP 751 was injected into rat models of acute and subacute bladder inflammation. IP 751 significantly suppressed bladder over activity in both animal models without affecting bladder contractility. By stopping the underlying cause of irritation - over activity of the bladder - IP 751 is able to eliminate the associated pain.

Perhaps more randomized trials in human beings could offer a new hope for the disease in the future.


Related medicine news :

1. Bladder Pain Suppressed By Marijuana-Derived Drug
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:

(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood ... people struggling with eating disorders as a result of the $20,000 raised at ... held at Fox Run Golf Club in Eureka, will help individuals who otherwise ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... announced that Chief Executive Officer Antonius Schuh, Ph.D., is ... th Annual Piper Jaffray Healthcare Conference. ... New York Palace Hotel in New York ... p.m. EST. Mr. Schuh will be available for one-on-one ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: